Apropos helps to better manage epilepsy on behalf of patients, their families, and their professional care team by using data collected from wearables, mobile devices, and environmental sensors.
Epilepsy is the most common neurologic condition worldwide, and there currently is no cure. The current active prevalence is approximately 3 million people, and nearly 200,000 people are newly diagnosed annually. While nearly 70% of patients are able to be well managed with medication in combination with other interventions, the process of optimal pharmacological treatment is far from trivial. Additionally, epilepsy represents a group of related conditions which are complicated by comorbidities.
The burdens of epilepsy are significant, especially when not managed optimally. These burdens include low quality of life, very high economic burden, complications from comorbidities, side effects from medication, poorer overall health. Moreover, these burdens frequently extend past the patient as many patients rely on assistance from informal caregivers such as family and friends. According to one study cited by the Centers for Disease Control and Prevention, epilepsy represents an estimated annual cost of $12.5 billion, where medication only accounts for 14% of direct costs. The key driver of costs are related to the heavy use of medical services among patients with epilepsy (such as unanticipated emergency room visits.
This data is then combined and analyzed to provide long-term monitoring of relevant health information.Through time-series analysis, Apropos algorithms can differentiate normal from abnormal patterns, which means that health anomalies can be predicted or monitored in real-time. Apropos uses this important information to provide actionable summaries and alerts to the right person and at the right time in order to manage this common condition through the web or mobile app. For example, with Apropos patients could easily identify previously-unknown triggers which could be avoided, and optimal dosages for medications could be easier to titrate with objective data describing seizure activity and side effects.
Some anticipated benefits include:
* Objective data recording and frictionless data sharing
* Support throughout the patient journey
* Improved patient experience - patients receive optimal management faster which increases quality of life, reduces undesired side-effects, and facilitates better communication with family and professional care team, and potential ability to return to work
* Improved health of populations - with improved management and actionable alerts, caregivers will experience less stress associated with constantly being alert to monitor for potential problems
* Reduced health care costs - optimal management implies fewer emergency department visits, falls, hospitalizations, and potential to gather data needed from spontaneous, unpredictable events from the patient's home
* Practicality - this solution is extensible and flexible, and can be accessed from the mobile or web application. Because there is the possibility of using existing wearables, the overall solution can expand to the patient's needs, budget, and preferences.
Easy one-click social registrationIs this safe?
We only receive the minimum information necessary to verify your account. We never get access to your friends/contacts or your profile, and we never post on your behalf. Your social account is used for logging in only.ORRegister via email
Send me updates on this Contest
In order to ensure a fair voting process and to make sure that no one votes more than once, we ask that you register either with a social networking account (easiest, only requires one click) or by registering with your email address (this will require you to click on a verification email that we will send you).
You only need to register once.